Blankson JN - Search Results

1

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.

Walker-Sperling VE, Pohlmeyer CW, Veenhuis RT, May M, Luna KA, Kirkpatrick AR, Laeyendecker O, Cox AL, Carrington M, Bailey JR, Arduino RC, Blankson JN. Walker-Sperling VE, et al. Among authors: blankson jn. EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26. EBioMedicine. 2017. PMID: 28159573 Free PMC article.

2

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.

Blankson JN, Gallant JE, Siliciano RF. Blankson JN, et al. J Infect Dis. 2001 Feb 15;183(4):657-61. doi: 10.1086/318545. Epub 2001 Jan 12. J Infect Dis. 2001. PMID: 11170994

3

The challenge of viral reservoirs in HIV-1 infection.

Blankson JN, Persaud D, Siliciano RF. Blankson JN, et al. Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024. Annu Rev Med. 2002. PMID: 11818490 Review.

4

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.

Bailey J, Blankson JN, Wind-Rotolo M, Siliciano RF. Bailey J, et al. Among authors: blankson jn. Curr Opin Immunol. 2004 Aug;16(4):470-6. doi: 10.1016/j.coi.2004.05.005. Curr Opin Immunol. 2004. PMID: 15245741 Review.

5

Crosscurrents in HIV-1 evolution.

Blankson JN, Bailey JR, Siliciano RF. Blankson JN, et al. Nat Immunol. 2006 Feb;7(2):121-2. doi: 10.1038/ni0206-121. Nat Immunol. 2006. PMID: 16424885 No abstract available.

6

Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.

Bailey JR, Lassen KG, Yang HC, Quinn TC, Ray SC, Blankson JN, Siliciano RF. Bailey JR, et al. Among authors: blankson jn. J Virol. 2006 May;80(10):4758-70. doi: 10.1128/JVI.80.10.4758-4770.2006. J Virol. 2006. PMID: 16641269 Free PMC article.

7

Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.

Bailey JR, Williams TM, Siliciano RF, Blankson JN. Bailey JR, et al. Among authors: blankson jn. J Exp Med. 2006 May 15;203(5):1357-69. doi: 10.1084/jem.20052319. Epub 2006 May 8. J Exp Med. 2006. PMID: 16682496 Free PMC article.

8

Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.

Blankson JN, Bailey JR, Thayil S, Yang HC, Lassen K, Lai J, Gandhi SK, Siliciano JD, Williams TM, Siliciano RF. Blankson JN, et al. J Virol. 2007 Mar;81(5):2508-18. doi: 10.1128/JVI.02165-06. Epub 2006 Dec 6. J Virol. 2007. PMID: 17151109 Free PMC article.

9

Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape.

Bailey JR, Zhang H, Wegweiser BW, Yang HC, Herrera L, Ahonkhai A, Williams TM, Siliciano RF, Blankson JN. Bailey JR, et al. Among authors: blankson jn. J Infect Dis. 2007 Jul 1;196(1):50-5. doi: 10.1086/518515. Epub 2007 May 17. J Infect Dis. 2007. PMID: 17538883

10

Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors.

Gandhi SK, Siliciano JD, Bailey JR, Siliciano RF, Blankson JN. Gandhi SK, et al. Among authors: blankson jn. J Virol. 2008 Mar;82(6):3125-30. doi: 10.1128/JVI.01533-07. Epub 2007 Dec 12. J Virol. 2008. PMID: 18077705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters